Cite
HARVARD Citation
Nakasone, H. et al. (2018). Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study). Hematological oncology. 36 (1), pp. 202-209. [Online].